CERo Therapeutics Holdings, Inc. Profile Avatar - Palmy Investing

CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell an…

Biotechnology
US, South San Francisco [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CERO's Analysis
CIK: 1870404 CUSIP: - ISIN: US71902K1051 LEI: - UEI: -
Secondary Listings
CERO has no secondary listings inside our databases.